(2016). A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels. Postgraduate Medical Journal, 205-208. https://doi.org/10.1136/postgradmedj-2016-134062